Industry
The Italian-based leader in the European nutraceutical CDMO market announces the acquisition of Nutraskills, a French company specialized in the research and development, production, and packaging of food supplements for…
The intestinal microflora of infants should contain a high proportion of Bifidobacteria during their first year of life to be well preserved and balanced
Company Presents Data at ESMO Congress Showing Link Between Gut Bacteria and Early Colorectal Cancer Detection
The acquisition is the culmination of a strategic partnership initiated in 2020 to accelerate the development of yeasts for sustainable production of fermented ingredients.
Holger Lenz discusses the interest of Bayer in the microbiome space during Microbiome Connect: Europe 2022.
Digbi Health is enrolled in Novo Nordisk's Global Prevention Accelerator Program for the prevention of obesity and related cardiometabolic conditions.
AcuraBio is a globally focussed organization bringing innovative therapeutics to market for customers in the biotech, pharmaceutical, and animal health industries.
Metabolon and the Oxford Parkinson's Disease Centre will identify new metabolomic biomarkers to advance Parkinson's research and detect new therapeutic targets
Simone Guglielmetti (University of Milan) discusses the use of inactivated microbes as alternative to live probiotics.
The partnership program aims to develop next-generation probiotics and therapeutics to modulate the gut microbiota to target areas like anxiety, depression and mental well-being.
